GAD1 contributes to the progression and drug resistance in castration resistant prostate cancer

BACKGROUND: Prostate cancer is currently the second most lethal malignancy in men worldwide due to metastasis and invasion in advanced stages. Studies have revealed that androgen deprivation therapy can induce stable remission in patients with advanced prostate cancer, although most patients will de...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Lilin, Liu, Yifan, Liu, Ruiji, Mao, Weipu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617133/
https://www.ncbi.nlm.nih.gov/pubmed/37904122
http://dx.doi.org/10.1186/s12935-023-03093-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617133/
https://www.ncbi.nlm.nih.gov/pubmed/37904122
http://dx.doi.org/10.1186/s12935-023-03093-4

Ejemplares similares